Stryker Q1 sales up 9.2% organic to $4.3B; lowers adjusted EPS guidance to lower end of $9.60-$10.00

STRYKER CORP

2022-Q1 EPS reported $0.84 revenue$4,275,000,000

Reported net sales $4.3B (+8.1%), organic +9.2%; MedSurg +10.8%, Orthopaedics and Spine +7.2%.
Adjusted EPS $1.97 (+2.1%); adjusted operating margin 21.8% contracted 170 bps.
Revised 2022 outlook: organic sales growth at high end of 6-8%; adjusted EPS at lower end of $9.60-$10.00.
Expects supply chain shortages and inflation to persist; currency headwind ~1.2% on sales, ~$0.10-$0.15 on adj. EPS.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.